Pivotal pharmacodynamic equivalence trial of Captisol-enabled intravenous clopidogrel.

Trial Profile

Pivotal pharmacodynamic equivalence trial of Captisol-enabled intravenous clopidogrel.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Oct 2012

At a glance

  • Drugs Clopidogrel (Primary) ; Clopidogrel (Primary)
  • Indications Coronary thrombosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Ligand Pharmaceuticals
  • Most Recent Events

    • 25 Oct 2012 Status changed from planning to recruiting, as reported in a Medicines Company media release.
    • 09 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top